Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 11 2023
09 11 2023
Historique:
received:
06
04
2023
accepted:
02
11
2023
medline:
13
11
2023
pubmed:
10
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
Obesity is the main risk factor for many non-communicable diseases. In clinical practice, unspecific markers are used for the determination of metabolic alterations and inflammation, without allowing the characterization of subjects at higher risk of complications. Circulating microRNAs represent an attractive approach for early screening to identify subjects affected by obesity more at risk of developing connected pathologies. The aim of this study was the identification of circulating free and extracellular vesicles (EVs)-embedded microRNAs able to identify obese patients at higher risk of type 2 diabetes (DM2). The expression data of circulating microRNAs derived from obese patients (OB), with DM2 (OBDM) and healthy donors were combined with clinical data, through network-based methodology implemented by weighted gene co-expression network analysis. The six circulating microRNAs overexpressed in OBDM patients were evaluated in a second group of patients, confirming the overexpression of miR-155-5p in OBDM patients. Interestingly, the combination of miR-155-5p with serum levels of IL-8, Leptin and RAGE was useful to identify OB patients most at risk of developing DM2. These results suggest that miR-155-5p is a potential circulating biomarker for DM2 and that the combination of this microRNA with other inflammatory markers in OB patients can predict the risk of developing DM2.
Identifiants
pubmed: 37945677
doi: 10.1038/s41598-023-46516-y
pii: 10.1038/s41598-023-46516-y
pmc: PMC10636008
doi:
Substances chimiques
MicroRNAs
0
Biomarkers
0
Circulating MicroRNA
0
MIRN155 microRNA, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19496Informations de copyright
© 2023. The Author(s).
Références
Metabolism. 2019 Mar;92:82-97
pubmed: 30502373
Clin Lab. 2019 Aug 1;65(8):
pubmed: 31414764
Kidney Res Clin Pract. 2020 Jun 30;39(2):115-117
pubmed: 32522893
J Mol Neurosci. 2017 Dec;63(3-4):320-332
pubmed: 29063445
Biomed Res Int. 2016;2016:9869208
pubmed: 28018919
Int J Biochem Cell Biol. 2015 Mar;60:197-201
pubmed: 25603271
Biochem Biophys Res Commun. 2011 Oct 28;414(3):618-24
pubmed: 21986534
PLoS Genet. 2016 Oct 6;12(10):e1006308
pubmed: 27711113
Noncoding RNA. 2021 Jul 07;7(3):
pubmed: 34287359
J Diabetes Res. 2016;2016:6809703
pubmed: 27547766
Sci Rep. 2020 Nov 10;10(1):19480
pubmed: 33173057
Cardiovasc Diabetol. 2022 Feb 24;21(1):31
pubmed: 35209901
Hypertension. 2012 Dec;60(6):1407-14
pubmed: 23108656
PLoS One. 2013 Oct 15;8(10):e77251
pubmed: 24204780
Exp Mol Med. 2017 Nov 24;49(11):e403
pubmed: 29170479
Sci Rep. 2017 Dec;7(1):47
pubmed: 28246388
Int J Mol Sci. 2020 Jun 04;21(11):
pubmed: 32512799
Diabetes Metab Syndr. 2022 Jan;16(1):102376
pubmed: 34954485
BMC Bioinformatics. 2019 Nov 4;20(1):545
pubmed: 31684860
Int J Endocrinol. 2018 Apr 10;2018:6872635
pubmed: 29849622
PLoS One. 2014 Dec 12;9(12):e115209
pubmed: 25500583
Cardiovasc Res. 2016 May 1;110(1):6-22
pubmed: 26912672
Gene. 2013 Dec 10;532(1):1-12
pubmed: 23246696
Fish Shellfish Immunol. 2020 Nov;106:28-35
pubmed: 32707297
J Clin Lab Anal. 2022 May;36(5):e24380
pubmed: 35349731
J Mol Cell Biol. 2012 Oct;4(5):341-3
pubmed: 22831835
J Mol Biomark Diagn. 2015 Nov;6(6):
pubmed: 27308097
J Mol Cell Cardiol. 2016 Aug;97:162-8
pubmed: 27192016
J Clin Endocrinol Metab. 2022 Jul 14;107(8):2267-2285
pubmed: 35532548
BMJ Open Diabetes Res Care. 2020 Sep;8(1):
pubmed: 32883688
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Int J Mol Sci. 2022 Apr 12;23(8):
pubmed: 35457094
Clin Diabetes Endocrinol. 2017 Jan 18;3:1
pubmed: 28702255
Mol Biol Rep. 2022 Aug;49(8):7783-7792
pubmed: 35733067
J Am Coll Cardiol. 2012 Jul 24;60(4):290-9
pubmed: 22813605
Tumour Biol. 2016 Apr;37(4):5185-92
pubmed: 26548866
Life Sci. 2018 Sep 1;208:201-207
pubmed: 30030064
J Endocrinol Invest. 2021 Jun;44(6):1159-1174
pubmed: 33111214
Metabolites. 2022 Dec 20;13(1):
pubmed: 36676927
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
J Biol Chem. 2011 Apr 1;286(13):11604-15
pubmed: 21282106
FASEB J. 2015 Sep;29(9):3595-611
pubmed: 26065857
Cell Metab. 2019 Feb 5;29(2):348-361.e6
pubmed: 30318337
Exp Ther Med. 2020 Nov;20(5):86
pubmed: 32968443
Nucleic Acids Res. 2016 Jan 4;44(D1):D239-47
pubmed: 26590260
J Interferon Cytokine Res. 2019 Jun;39(6):321-330
pubmed: 30998423
Lancet. 2017 Jun 3;389(10085):2163
pubmed: 28589879
J Am Heart Assoc. 2020 Dec 15;9(24):e017000
pubmed: 33317369
J Cell Biochem. 2015 Dec;116(12):2870-81
pubmed: 26012521
Elife. 2015 Aug 12;4:
pubmed: 26267216